SAPHNELO (Anifrolumab-fnia)

**Product type:** Human Prescription Drug

**Active ingredient:** ANIFROLUMAB

**Strength:** 300 mg/2mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** AstraZeneca Pharmaceuticals LP

**Marketing category:** BLA (BLA761123)

**Pharmacologic class:** Type I Interferon Receptor Antagonist [EPC], Type I Interferon Receptor Antagonists [MoA]